Showing results (41-50 of 139) with videos related to
Sort By:
Pageof 14
Journal of the American Academy of Dermatology|August 23, 2005
The role of cytotoxic skin-homing CD8+ lymphocytes in cutaneous cytotoxic T-cell lymphoma and pityriasis lichenoidesJoerg Wenzel, Ines Gütgemann, Moritz Distelmaier, et al.Dermatologie (Heidelberg, Germany)|August 14, 2024
[Sarcopenia and immune-related toxicity in patients with malignant melanoma undergoing immune checkpoint inhibition]Christian Holtorf, Miriam Mengoni, Thomas Tüting, et al.Journal of Cancer Research and Clinical Oncology|May 25, 2024
Low skeletal muscle mass predicts melanoma-specific survival in melanoma patients treated with adjuvant immune checkpoint blockadeMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|June 10, 2024
Comprehensive analysis of body composition features in melanoma patients treated with tyrosine kinase inhibitorsMiriam Mengoni, Andreas Dominik Braun, Mattes Simon Hinnerichs, et al.The Journal of Pathology|February 3, 2005
Enhanced type I interferon signalling promotes Th1-biased inflammation in cutaneous lupus erythematosusJoerg Wenzel, Eva Wörenkämper, Silke Freutel, et al.Cancer Research|May 19, 2006
Therapeutic efficacy of antigen-specific vaccination and toll-like receptor stimulation against established transplanted and autochthonous melanoma in miceDamia Tormo, Aleix Ferrer, Pilar Bosch, et al.Leukemia Research|November 24, 2005
Additional Her 2/neu gene copies in patients with Sézary syndromeJochen Utikal, Nina Poenitz, Alexei Gratchev, et al.STAR Protocols|January 21, 2022
CRISPitope: A generic platform to model target antigens for adoptive T cell transfer therapy in mouse tumor modelsMaike Effern, Nicole Glodde, Emma Bawden, et al.The Journal of Investigative Dermatology|August 20, 2010
Evidence for a pathophysiological role of keratinocyte-derived type III interferon (IFNλ) in cutaneous lupus erythematosusSabine Zahn, Claudia Rehkämper, Beate M Kümmerer, et al.International Journal of Cancer|October 30, 2004
Impact of p53-based immunization on primary chemically-induced tumorsVito R Cicinnati, Grzegorz Dworacki, Andreas Albers, et al.Pageof 14